SSJ_Redacted.pdf

This is a Sole Source Justification (SSJ) for a follow-on requirement under the Simplified Acquisition Threshold prepared by the Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – West (HCD-W) in San Diego, California.

The requirement is for blood bag supplies to support the TERUFLEX® whole blood collection system manufactured by Terumo BCT Inc. and distributed by Metro Medical Equipment & Supply (MMES), a Women-Owned Small Business (WOSB). The supplies will be delivered to Naval Hospital Okinawa (NHO) in Japan to support the Armed Services Blood Bank Center (ASBBC). The contract type is Fixed Price with a base delivery date of September 30, 2026, and four option years extending through September 30, 2030. The funding type is Operations and Maintenance (O&M). Shipping is directed to Cardinal Health MPS Distribution Center in Ontario, California, with final delivery to Camp Foster BLDG 966, Taraawa Road, Ginowan Shi, Okinawa Japan.

The justification cites Terumo BCT, Inc. as the sole manufacturer of the proprietary TERUFLEX® blood bag system with the specific CPD A-1 solution and 500 mL collection bags (model UBBDC D506A2) required for NHO ASBBC operations. Market research conducted in December 2025 and January 2026 confirmed that only Terumo's blood bags meet the Government's requirements and that WOSB concerns are substantially underrepresented in Federal procurement. The Notice of Intent was posted on SAM.gov from January 12-14, 2026, with no additional sources submitting capabilities statements. The authority for this sole source award is FAR Subpart 13.5 for simplified acquisition of commercial items, with WOSB set-aside in accordance with FAR 13.003(b)(2)(iv), 13.501(a), and 19.1506(b).